Claret Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.6M | Sell |
113,760
-250
| -0.2% | -$29.3K | 1.57% | 22 |
|
|
2026
Q1 | $13.7M | Buy |
114,010
+1,055
| +0.9% | +$122K | 1.64% | 20 |
|
|
2025
Q4 | $11.9M | Sell |
112,955
-506
| -0.4% | -$47.5K | 1.38% | 21 |
|
|
2025
Q3 | $9.52M | Buy |
113,461
+61,285
| +117% | +$5.05M | 1.13% | 24 |
|
|
2025
Q2 | $4.13M | Buy |
+52,176
| New | +$4.15M | 0.53% | 41 |
|
|
2025
Q1 | – | Sell |
-7,843
| Closed | -$732K | – | 91 |
|
|
2024
Q4 | $780K | Sell |
7,843
-187
| -2% | -$19.3K | 0.12% | 83 |
|
|
2024
Q3 | $912K | Sell |
8,030
-15
| -0.2% | -$1.78K | 0.15% | 68 |
|
|
2024
Q2 | $996K | Buy |
8,045
+207
| +3% | +$26.7K | 0.18% | 66 |
|
|
2024
Q1 | $1.03M | Hold |
7,838
| – | – | 0.17% | 65 |
|
|
2023
Q4 | $854K | Sell |
7,838
-25
| -0.3% | -$2.6K | 0.15% | 69 |
|
|
2023
Q3 | $809K | Buy |
7,863
+15
| +0.2% | +$1.62K | 0.16% | 66 |
|
|
2023
Q2 | $906K | Buy |
7,848
+75
| +1% | +$8.52K | 0.18% | 63 |
|
|
2023
Q1 | $827K | Sell |
7,773
-100
| -1% | -$10.8K | 0.16% | 69 |
|
|
2022
Q4 | $874K | Hold |
7,873
| – | – | 0.19% | 67 |
|
|
2022
Q3 | $678K | Sell |
7,873
-20
| -0.3% | -$1.78K | 0.16% | 70 |
|
|
2022
Q2 | $720K | Buy |
7,893
+14
| +0.2% | +$1.24K | 0.16% | 74 |
|
|
2022
Q1 | $646K | Sell |
7,879
-10
| -0.1% | -$788 | 0.12% | 79 |
|
|
2021
Q4 | $605K | Sell |
7,889
-36
| -0.5% | -$2.87K | 0.11% | 86 |
|
|
2021
Q3 | $595K | Buy |
7,925
+20
| +0.3% | +$1.52K | 0.1% | 94 |
|
|
2021
Q2 | $615K | Sell |
7,905
-549
| -6% | -$40.8K | 0.1% | 94 |
|
|
2021
Q1 | $622K | Sell |
8,454
-192
| -2% | -$14.2K | 0.12% | 99 |
|
|
2020
Q4 | $675K | Sell |
8,646
-84
| -1% | -$6.42K | 0.13% | 83 |
|
|
2020
Q3 | $691K | Sell |
8,730
-409
| -4% | -$32K | 0.15% | 83 |
|
|
2020
Q2 | $674K | Sell |
9,139
-439
| -5% | -$33K | 0.16% | 82 |
|
|
2020
Q1 | $703K | Sell |
9,578
-2
| -0% | -$157 | 0.2% | 74 |
|
|
2019
Q4 | $831K | Sell |
9,580
-61
| -0.6% | -$5.01K | 0.16% | 84 |
|
|
2019
Q3 | $774K | Hold |
9,641
| – | – | 0.16% | 88 |
|
|
2019
Q2 | $771K | Hold |
9,641
| – | – | 0.16% | 88 |
|
|
2019
Q1 | $765K | Sell |
9,641
-33
| -0.3% | -$2.47K | 0.15% | 91 |
|
|
2018
Q4 | $705K | Buy |
9,674
+5
| +0.1% | +$353 | 0.16% | 95 |
|
|
2018
Q3 | $654K | Sell |
9,669
-31
| -0.3% | -$1.98K | 0.13% | 95 |
|
|
2018
Q2 | $562K | Hold |
9,700
| – | – | 0.11% | 100 |
|
|
2018
Q1 | $504K | Hold |
9,700
| – | – | 0.11% | 103 |
|
|
2017
Q4 | $521K | Buy |
+9,700
| New | +$538K | 0.11% | 103 |
|
Other funds holding MRK
ATO
Claret Asset Management's MRK Position: Q2 2026 in Review
Claret Asset Management reduced its Merck (MRK) stake by 0.22% in Q2 2026, selling an estimated $29.3K and leaving 113,760 shares worth $14.6M. The position accounts for 1.57% of the portfolio, ranked #22.
Claret Asset Management first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Claret Asset Management held 113,760 shares of Merck worth $14.6M as of Q2 2026.
- Claret Asset Management sold 250 Merck shares in Q2 2026, an estimated $29.3K.
- Merck made up 1.57% of Claret Asset Management's portfolio in Q2 2026, its #22 holding.
- Claret Asset Management first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.